Due to COVID-restrictions Magnus Group virtually hosted its premier event “International Alzheimer’s Disease & Dementia Conference” (Dementia 2022) during June 15-16, 2022.
The conference's central theme was “Explicating Advancements to Combat the Silent Epidemic of Dementia and Alzheimer” and it had the goal of presenting hope through fresh research, information, and Alzheimer- dementia related treatments.
DEMENTIA 2022 attracted a large number of delegates and representatives from different organisations because of its virtual format. The conference, which featured presenters, keynote sessions, plenary talks, invited lectures, discussion panels and poster presentations, drew many attendees from 46 nations. They shared their research, ideas, and experiences in a spirit of cooperation and solidarity against the backdrop of the worldwide COVID-19 pandemic. The global summit also offered health care professionals insights on how to enhance support for families caring for loved ones with these diseases and improve care delivery for those living with dementia and Alzheimer's disease. Additionally, it offered practical advice on how people and families can successfully manage the caring path.
Title : Can we stimulate neuroplasticity with the cell signaling molecule ghrelin?
Irina Stoyanova, Medical University of Varna, Bulgaria
Title : Sleep quality improvement for Alzheimer’s disease
Benyi Li, University of Kansas, United States
Title : Breakthrough in Dementia
Esther Ebenezer, UniKL Royal College of Medicine Perak, Malaysia
Title : Implications for Serum Amyloid P in the Pathogenesis of Alzheimer’s Disease
Mark S Kindy, University of South Florida and the James A. Haley VA Hospital, United States
Title : Memory decline in dementia and its impact on spoken spontaneous discourse production
Anthony Pak-Hin Kong, The University of Hong Kong, Hong Kong
Title : Brain insulin resistance in Alzheimer’s disease: can phytochemicals exert beneficial effects?
Mario Allegra, University of Palermo, Italy